Press note – Procare Health

Press

Procare Health

Categories

Feactured Post

New ovarian cancer drug could give women years of life in the form of a ‘therapeutic’ vaccine

13 de October de 2021

Last post

New ovarian cancer drug could give women years of life in the form of a ‘therapeutic’ vaccine

13 de October de 2021

Global Human Papillomavirus (HPV) Vaccine Market Could Exceed $12 Billion By 2027

12 de February de 2021

BioVaxys Technology and Procare Health Announce Broad CoDevelopment for Cancer and Viral Vaccines

12 de February de 2021

New ovarian cancer drug could give women years of life in the form of a ‘therapeutic’ vaccine

13 de October de 2021

Global Human Papillomavirus (HPV) Vaccine Market Could Exceed $12 Billion By 2027

12 de February de 2021

BioVaxys Technology and Procare Health Announce Broad CoDevelopment for Cancer and Viral Vaccines

12 de February de 2021

Press

Procare Health

New ovarian cancer drug could give women years of life in the form of a ‘therapeutic’ vaccine

13 de October de 2021

Global Human Papillomavirus (HPV) Vaccine Market Could Exceed $12 Billion By 2027

12 de February de 2021

BioVaxys Technology and Procare Health Announce Broad CoDevelopment for Cancer and Viral Vaccines

12 de February de 2021

SOCIAL HEADQUARTER
Avda. Miguel Hernández 21, Bajo
46450 Benifaio (Valencia – Spain)

BUSINESS HEADQUARTER
Paseo del Ferrocarril, 339 08860 Castelldefels, Barcelona +34 93 645 54 41 [email protected]

Products

Procare Health

Follow us

Privacy Policy

Cookies policy

© 2021 Procare Health

Certificates

headquarters

SOCIAL HEADQUARTER
Avda. Miguel Hernández 21, Bajo
46450 Benifaio (Valencia – Spain)

BUSINESS HEADQUARTER
Paseo del Ferrocarril, 339 08860 Castelldefels, Barcelona +34 93 645 54 41 [email protected]

Procare Health

Procare Health in the world

business-development

Product area

Privacy

© 2021 Procare Health